Continuum Advisory’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9
Closed -$1.35K 641
2025
Q1
$1.35K Sell
9
-9
-50% -$1.51K ﹤0.01% 1452
2024
Q4
$3.32K Hold
18
﹤0.01% 1251
2024
Q3
$3.54K Buy
18
+2
+13% +$416 ﹤0.01% 1254
2024
Q2
$3.31K Hold
16
﹤0.01% 1180
2024
Q1
$3.68K Buy
+16
New +$3.82K ﹤0.01% 1137
2023
Q3
Sell
-997
Closed -$210K 455
2023
Q2
$210K Buy
+997
New +$198K 0.03% 425
2022
Q3
Sell
-1,130
Closed -$242K 409
2022
Q2
$242K Sell
1,130
-296
-21% -$72.3K 0.04% 363
2022
Q1
$344K Buy
1,426
+781
+121% +$241K 0.07% 292
2021
Q4
$243K Sell
645
-97
-13% -$37.7K 0.05% 265
2021
Q3
$306K Hold
742
0.08% 223
2021
Q2
$274K Buy
+742
New +$248K 0.09% 222

Other funds holding CRL